-
Chaodong Wu - Professor and Faculty Fellow
- Office:
- 217A Cater-Mattil
- Email:
- cdwu@tamu.edu
- Phone:
- 979-458-1521
- http://nfscfaculty.tamu.edu/wu
- Undergraduate Education
- Hubei University of Chinese Medicine (Wuhan), China. MD, Medicine, 1992
- Graduate Education
- Tongji Medical University (Wuhan), China. Master of Medical Science, 1995
- Beijing Medical University, China. PhD in Medical Science, 1998
- Awards
- Junior Faculty Award, American Diabetes Association, 2010
- Research Award, Minnesota Medical Foundation, 2004
- Travel Award, Dept. of BMBB, the University of Minnesota, 2001
- Pilot & Feasibility Research Award, Minnesota Obesity Center, 2002, 2005
- Travel Award, The Center for Diabetes Research, University of Minnesota, 2001
- Courses Taught
- NUTR 470: Nutrition and Physiological Chemistry
- NUTR 681: Nutrition Seminar
Research Interest
The long-term goal of Dr. Wu’s research program is to elucidate the mechanisms underlying the pathogenesis of obesity and overnutrition-associated metabolic diseases including insulin resistance, diabetes, and fatty liver disease so that novel dietary and/or pharmacological approaches can be developed for preventing and/or treating metabolic diseases. Using molecular, cellular, and integrative approaches, the Wu lab is focused on investigating the interaction between metabolism and inflammation.
Research Area
Obesity, insulin resistance, diabetes, and fatty liver disease
Publications
<!-- load from cache
-->
-->
- Li, H, Guo, X, Aquino, E, Wu, C. Mini review: STING activation during non-alcoholic fatty liver disease. Front Nutr. 2023;10 :1139339. doi: 10.3389/fnut.2023.1139339. PubMed PMID:36937350 PubMed Central PMC10014842.
- Kundu, D, Kennedy, L, Zhou, T, Ekser, B, Meadows, V, Sybenga, A et al.. p16 INK4A drives non-alcoholic fatty liver disease phenotypes in high fat diet fed mice via biliary e2f1/foxo1/igf-1 signaling. Hepatology. 2023; :. doi: 10.1097/HEP.0000000000000307. PubMed PMID:36799449 .
- Wu, N, Zhou, T, Carpino, G, Baiocchi, L, Kyritsi, K, Kennedy, L et al.. Prolonged administration of a secretin receptor antagonist inhibits biliary senescence and liver fibrosis in Mdr2-/- mice. Hepatology. 2023; :. doi: 10.1097/HEP.0000000000000310. PubMed PMID:36799446 .